Related Experiment Video
Updated: May 10, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
Pearls & Oy-sters: Stroke Recurrence After PFO Closure Uncovers Cerebrotendinous Xanthomatosis
Lanyu Liu1, Ying Wang1, Xiujia Chen2
1Department of Neurology, Taizhou Hospital of Zhejiang Province, Affiliated to Wenzhou Medical University, Linhai City, China.
Insights
Cerebrotendinous xanthomatosis (CTX) causes early atherosclerosis and stroke in young adults. This case highlights CTX as a cause of recurrent stroke, even after PFO closure, emphasizing early diagnosis for better outcomes.
Area of Science:
- Neurology
- Metabolic Disorders
- Genetics
Background:
- Cerebrotendinous xanthomatosis (CTX) is a rare metabolic disorder.
- CTX can lead to premature atherosclerosis and ischemic stroke in young individuals.
- Recurrent strokes in young adults necessitate a thorough etiological investigation.
Abstract:
Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive metabolic disorder that can cause premature atherosclerosis and ischemic stroke in young adults. We report a 23-year-old man who had recurrent strokes even after patent foramen ovale (PFO) closure. Initial evaluation for his first cryptogenic stroke revealed a PFO with a high Risk of Paradoxical Embolism (RoPE) score, leading to closure. Three years later, he experienced a recurrent stroke with right M1 segment occlusion. High-resolution magnetic resonance vessel wall imaging demonstrated intracranial atherosclerotic plaque, prompting reconsideration of the etiology. Further history taking revealed chronic diarrhea since infancy and juvenile cataracts. Examination showed borderline intellectual functioning, bilateral ankle clonus, and Achilles tendon xanthomas. Brain MRI exhibited characteristic bilateral dentate nucleus hyperintensities. Genetic testing confirmed CYP27A1 pathogenic variants, consistent with a diagnosis of CTX. Through highlighting CTX underlying premature atherosclerosis and stroke in a young man, this case emphasizes the importance of rare metabolic disorders in stroke, even when a common cause such as PFO is identified. Early recognition enables targeted therapy and improves outcomes.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Pneumothorax-II
Clinical Manifestations:
Hemorrhagic Stroke ll: Pathophysiology
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

